James S Scibetta Insider Trading $PCRX Pacira BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James S Scibetta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James S Scibetta. James S Scibetta is President in Pacira Pharmaceuticals, Inc. ($PCRX) and President & CFO in Pacira Pharmaceuticals, Inc. ($PCRX) and SVP, Chief Financial Officer in Pacira Pharmaceuticals, Inc. ($PCRX) and in Aquestive Therapeutics, Inc. ($AQST) and Director in Matinas BioPharma Holdings, Inc. ($MTNB).
James S Scibetta in Pacira BioSciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James S Scibetta: President & CFO, SVP, Chief Financial Officer
Holdings: 25,118 shares
Current Value: $1,048,677
Latest Transaction: Jun 07 2017
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James S Scibetta in Pacira BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AQST, MTNB, PCRX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 43.32 | 1,966 | 85,169 | 25,118 | 27.1 K to 25.1 K (-7.26 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 20,000 | 109,800 | 15,251 | |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 51.20 | 20,000 | 1,024,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| May 17 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 20,000 | 109,800 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 5.49 | 17,627 | 96,772 | 35,251 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 2,373 | 3,821 | 0 | |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.97 | 4,997 | 194,733 | 27,084 | 32.1 K to 27.1 K (-15.58 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 38.39 | 15,003 | 575,965 | 32,081 | 47.1 K to 32.1 K (-31.86 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 5.49 | 17,627 | 96,772 | 47,084 | 29.5 K to 47.1 K (+59.84 %) |
| Jan 19 2017 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 2,373 | 3,821 | 29,457 | 27.1 K to 29.5 K (+8.76 %) |
| Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | A | 32.35 | 20,000 | 647,000 | 20,000 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 20,000 | 32,200 | 2,373 | |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 36.50 | 20,000 | 730,000 | 27,084 | 47.1 K to 27.1 K (-42.48 %) |
| Nov 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 20,000 | 32,200 | 47,084 | 27.1 K to 47.1 K (+73.84 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 15,877 | 25,562 | 22,373 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Option Exercise | M | 1.61 | 9,123 | 14,688 | 0 | |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Sell | S | 45.21 | 25,000 | 1,130,250 | 27,084 | 52.1 K to 27.1 K (-48.00 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 15,877 | 25,562 | 52,084 | 36.2 K to 52.1 K (+43.85 %) |
| Aug 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President | Buy | M | 1.61 | 9,123 | 14,688 | 36,207 | 27.1 K to 36.2 K (+33.68 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 40.34 | 32,500 | 1,311,050 | 32,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Grant | A | 0.00 | 16,250 | 0 | 26,754 | 10.5 K to 26.8 K (+154.70 %) |
| Nov 05 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 55.34 | 40,000 | 2,213,600 | 40,000 | |
| Sep 14 2015 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | SVP, Chief Financia ... | Buy | P | 61.37 | 5,000 | 306,850 | 10,504 | 5.5 K to 10.5 K (+90.84 %) |
Page: 1